Week of 11/17

The rapid development in artificial intelligence over recent months has stirred plenty of conversations between industry experts, investors, and consumers. As a result, analysts seek to understand whether AI will be a long-term application to businesses and consumers or if the buy-in for this technology will come crashing down. Not only are U.S. companies investing heavily in the future, like OpenAI committing to spending $1.4 trillion on datacenters in the coming years , but

In October 2025, NVIDIA soared to reach a milestone market valuation of approximately 5 trillion dollars . This places NVIDIA at the top of the most valuable companies in history. This extraordinary figure reflects growth in areas such as AI Hardware, autonomous systems, and data-center computing. The company’s domination of the production and supply of graphics-processing units (GPUs) has been amplified by the growth of Artificial Intelligence and an increased demand for new

The Indianapolis-based pharmaceutical giant Eli Lilly (NYSE: LLY), maker of the popular weight-loss drug Zepbound, is fully embracing artificial intelligence in a bid to discover new drugs in an increasingly competitive pharmaceutical landscape. In late October 2025, Lilly announced a partnership with Nvidia (Nasdaq: NVDA) to build what it calls the “industry’s most powerful AI supercomputer,”an “AI factory” housed in its Indianapolis data center and powered by more than 1,00

On the night of the New York City mayoral election, several major real estate investment trusts (REITs) focused in the city, such as Empire State Realty Trust, Vornado, and SL Green, all saw their shares fall between 1% and 5%, with some sliding further the next morning. According to Alan Rosinsky , founder of Metro Manhattan Office Space, “stocks that are heavily influenced by NYC events heard mayor-elect Zohran Mamdani’s victory speech and immediately freaked out.” Members